Future implications of polygenic risk scores for life insurance underwriting

https://pubmed.ncbi.nlm.nih.gov/38555372/ Future implications of polygenic risk scores for life insurance underwriting. Tatiane Yanes et al. NPJ Genom Med 2024 3 (1) 25 From the abstract: "As PGS is increasingly utilized in research and clinical practice, it is pivotal that careful consideration is given to the potential insurance implications of PGS to ensure consumer protection against GD. For the full potential benefits of PGS to be realized, and its clinical utility determined across various use cases, individuals will need to be confident that they can participate in research studies and access clinical genetic testing without fear of insurance discrimination. Clarification is needed regarding the extent to which existing protections and legislation relating to monogenic testing may also extend to PGS test results. "